Dermata Therapeutics announced the enrollment of the first participant in a clinical trial evaluating Tome Clearing Treatment, its once-weekly acne therapy. The company expects to launch this second commercial product in the first half of 2027. Dermata Therapeutics operates in the dermatology and consumer skincare industry.
